17-20451858-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001367292.2(LGALS9B):c.698C>T(p.Pro233Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000686 in 1,471,986 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001367292.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LGALS9B | NM_001367292.2 | c.698C>T | p.Pro233Leu | missense_variant | 9/11 | ENST00000423676.8 | NP_001354221.1 | |
LGALS9B | NM_001042685.3 | c.695C>T | p.Pro232Leu | missense_variant | 9/11 | NP_001036150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS9B | ENST00000423676.8 | c.698C>T | p.Pro233Leu | missense_variant | 9/11 | 1 | NM_001367292.2 | ENSP00000388841.3 |
Frequencies
GnomAD3 genomes AF: 0.000266 AC: 33AN: 124064Hom.: 2 Cov.: 18
GnomAD3 exomes AF: 0.0000736 AC: 16AN: 217250Hom.: 3 AF XY: 0.0000597 AC XY: 7AN XY: 117182
GnomAD4 exome AF: 0.0000505 AC: 68AN: 1347790Hom.: 12 Cov.: 30 AF XY: 0.0000493 AC XY: 33AN XY: 669984
GnomAD4 genome AF: 0.000266 AC: 33AN: 124196Hom.: 2 Cov.: 18 AF XY: 0.000283 AC XY: 17AN XY: 60070
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.695C>T (p.P232L) alteration is located in exon 9 (coding exon 9) of the LGALS9B gene. This alteration results from a C to T substitution at nucleotide position 695, causing the proline (P) at amino acid position 232 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at